Laboratorios IFA

Laboratorios IFA, established in 1988, is a key player in Bolivia's pharmaceutical and healthcare sectors. The company is dedicated to safeguarding client health by producing high-quality pharmaceutical products under strict Good Manufacturing Practices (GMP). Utilizing advanced technology in its production processes, Laboratorios IFA also maintains a specialized pharmacovigilance department to monitor medication safety and efficacy. This commitment to excellence has earned them recognition in Bolivia's corporate reputation rankings, serving a diverse clientele seeking reliable healthcare solutions.

Operating with 500 - 1,000 employees, Laboratorios IFA focuses on delivering effective healthcare solutions. Their pharmacovigilance unit is vital for post-market surveillance, ensuring ongoing safety. The company's dedication to technological advancement and rigorous quality control supports its mission to enhance public health. Insights into the team driving these efforts are available via Meet Laboratorios IFA's team. This integration of technology and skilled personnel underpins their operational strategy and commitment to patient well-being.

With an annual revenue of $49.1M, Laboratorios IFA serves both B2B and B2C markets, demonstrating broad reach. Their product portfolio addresses varied healthcare needs, reinforcing their position as a trusted provider. The company's strategic focus on quality, safety, and innovation, coupled with its established reputation, solidifies its role in the South American healthcare landscape. Operations are centered in Santa Cruz de la Sierra, Bolivia, serving as the hub for product delivery and client support.